1. Field of the Invention
In general, the present invention relates to the structure of pharmaceutical vials and especially the structure of caps for such vials. The present invention also relates to electronic devices that monitor the viability of the contents of a pharmaceutical vial.
2. Prior Art Description
Many pharmaceutical products are administered by injection. In many instances, the pharmaceutical product is packaged in a vial by the manufacturer. To prevent contamination of the pharmaceutical product, the vial is sealed with a piercable cap. In order to access the contents of the vial, a needle from a hypodermic syringe must be driven through the structure of the cap. Once the tip of the needle is inside the vial, the pharmaceutical product can be drawn out of the vial by the operation of the syringe.
Some vials contain enough pharmaceutical product for a single dose to a single patient. Other vials contain enough pharmaceutical products for multiple patients. Vials that contain enough pharmaceutical product for multiple patients have a cap structure that will be pieced by multiple hypodermic syringes at various times. When the needle of a hypodermic syringe pierces a cap, it creates a hole. If this hole is not closed, the hole leaves a passage for bacteria, air, and moisture to contaminate the contents of the syringe. In order to prevent such contamination, many pharmaceutical manufacturers utilize safety caps on vials that automatically reseal each time they are pierced by a needle. Such safety caps are exemplified by U.S. Pat. No. 4,815,619 to Turner, entitled Medicament Vial Safety Cap. Additionally, industry utilizes single/multiple use pre-filled syringes for pharmaceutical product distribution to patients.
Many pharmaceutical products, such as vaccines, can be compromised not only by contamination but also by variations in temperature and the passage of time. Many pharmaceutical products have a posted shelf life. If the pharmaceutical product stands unused for longer than its shelf life, the pharmaceutical product loses potency and may no longer be effective. Furthermore, many pharmaceutical products are highly sensitive to temperature. If the temperature of a pharmaceutical product is too high, molecules within the product may break down. Likewise, if a pharmaceutical product becomes too cold, emulsions may separate into component ingredients. In either case, the pharmaceutical product may be rendered useless.
In order to monitor the temperature and shelf life of pharmaceutical products, electronic devices have been created that are packaged with the pharmaceutical products. Such electronic monitoring devices are exemplified by U.S. Pat. No. 6,810,350 to Blakely, entitled Determination Of Pharmaceutical Expiration Date. Such electronic devices produce an audible alarm if the pharmaceutical product is expired or has been temperature compromised. However, such prior art electronic monitoring devices have many disadvantages. Since such prior art monitoring devices are units that are separate and distinct from the vials/prepackaged syringes that hold the pharmaceutical product, the electronic devices are often attached to the packaging of the vial/prepackaged syringes or the shipping container of the vial. Once individual vials/prepackaged syringes are removed from their shipping containers, they become separated from the electronic monitoring device. The individual vials/prepackaged syringes may then become compromised without detection. Furthermore, prior art electronic monitoring devices are battery operated. If the battery dies, the electronic monitor stops working. A person may then think that a very old vial is good. The same situation may occur if the electronic monitoring device becomes damaged during shipping or accidentally gets wet and stops working.
A need therefore exists for an improved monitoring device that monitors the age and temperature history of a pharmaceutical product in a vial/prepackaged syringe, yet cannot be separated from the pharmaceutical vial/prepackaged syringe. A need also exists for a monitoring device that prevents a compromised pharmaceutical product from being used, even if the monitoring device itself is damaged. These needs are met by the present invention as described and claimed below.
The present invention is a cap assembly for a container that holds a perishable product, wherein the perishable product has a predetermined shelf life. The cap assembly attaches to the container. The cap assembly defines an opening through which the perishable product inside the container can be accessed. At least one obstruction plate is present within the cap assembly. Each obstruction plate is positionable between an open position, where the obstruction plate is clear of the opening, and a closed position where the obstruction plate obstructs the opening.
A mechanism is provided within the cap assembly that automatically moves each obstruction plate from its open position to its closed position when the shelf life of the perishable product has expired. Each plate is preferably red in color, or otherwise highly visible, to provide a clear indication that the perishable product is no longer useful. Optionally, the cap assembly may also include at least one condition sensor for detecting a condition harmful to the perishable product in the container. The mechanism may also close each obstruction plate if such a harmful condition is detected by a condition sensor.
For a better understanding of the present invention, reference is made to the following description of exemplary embodiments thereof, considered in conjunction with the accompanying drawings, in which:
Although the present invention can be used to monitor the expiration date and the temperature history of many different types of perishable products, such as milk in a container, the present invention is especially well suited for monitoring such variables for a pharmaceutical product packaged in a vial. Accordingly, the first exemplary embodiment of the present invention shows its application to a vial in order to set forth the best mode contemplated for the invention. However, it will be understood that the use of the present invention on a vial is only one use and should not be considered a limitation.
Referring to
If the pharmaceutical product 12 in the vial 10 is uncompromised, the central opening 24 in the cap assembly 10 remains unobstructed. The needle 16 of a hypodermic syringe 18 can therefore be advanced through the central opening 24 and into the pierceable barrier 14. The pharmaceutical product 12 can therefore be drawn into the hypodermic syringe 18 in the same manner as if the cap assembly 20 were not present.
Referring to
Referring to
The first, second and third obstruction plates 25, 26, 27 can be rotated into an open position. (Shown in
The obstruction plates 25, 26, 27 are held open against the bias of the spring 30 by a trigger pin 32. As is shown in
Referring to
It is preferred that the closed orientation of the obstruction plates 25, 26, 27 be the failsafe position. In this manner, should the battery that powers the cap assembly 20 fail, or should the electronics become damaged, the obstruction plates 25, 26, 27 automatically move from the open position of
Referring to
Once the control circuit 36 has the data for the expiration date and temperature criteria, the control circuit 36 monitors both time and temperature. See Blocks 42, 44. Time is monitored by a clock built into the control circuit 36. As can be seen from Block 46, the control circuit 36 compares the elapsed time to the shelf life of the pharmaceutical product. If the elapsed time exceeds the shelf life, then the control circuit 36 triggers the mechanical activator 34 and the obstruction plates 25, 26, 27 move from their open position into their closed position. See Block 48.
Temperature is monitored by a temperature sensor 38 that is connected to the control circuit 36. If the cap assembly 20 experiences an out-of-range temperature for a predetermined period of time, then the control circuit 36 triggers the mechanical activator 34 and the obstruction plates 25, 26, 27 move from their open position into their closed position. See Blocks 50 and 48. Brief exposures to high or low temperatures do not cause the control circuit to trigger the mechanical activator 34. Rather, the exposure to a temperature extreme must be for a period of time sufficient to compromise the integrity of the pharmaceutical product being stored. It will therefore be understood that the control circuit monitors its internal clock while detecting a temperature extreme.
The criteria for expiration date and temperature parameters vary widely for different pharmaceuticals. Some pharmaceutical products can only be kept for short times in narrow temperature ranges. Other pharmaceuticals can last for years at most any temperature. The sensitivity of the temperature sensor and the precision of the clock can therefore be altered to match the needs of a specific pharmaceutical product.
In the first embodiment of the present invention that is presented, the cap assembly 20 is used to stop access to a vial, should the contents of the vial become compromised. Referring to
In use, a person opens the safety cap 64 and shakes the pills 62 out of the container 60 for consumption. The pills 62 pass through the central opening 24 in the center of the cap assembly 20. However, if the pills 62 have expired or have been compromised by temperature, then the cap assembly 20 automatically closes. Once the cap assembly 20 closes, the pills 62 can no longer be removed from the container 60.
It will be understood that the embodiments of the present invention that are described are merely exemplary and that a person skilled in the art can make many variations to those embodiments using functionally equivalent parts. For instance, in the shown embodiments, a sensor for temperature is provided. Other sensors, such as sensors for humidity or light exposure can also be used. Obviously, such sensors would be used with pharmaceutical products that are adversely affected by humidity and/or light. All such variations, modifications, and alternate embodiments are intended to be included within the scope of the present invention as claimed.
Number | Name | Date | Kind |
---|---|---|---|
3762601 | McLaughlin | Oct 1973 | A |
4504153 | Schollmeyer et al. | Mar 1985 | A |
4815619 | Turner et al. | Mar 1989 | A |
6131399 | Hall | Oct 2000 | A |
6169707 | Newland | Jan 2001 | B1 |
6259654 | de la Huerga | Jul 2001 | B1 |
6810350 | Blakley | Oct 2004 | B2 |
20020047019 | Devers | Apr 2002 | A1 |
20030183642 | Kempker, Sr. | Oct 2003 | A1 |
20060071011 | Varvarelis et al. | Apr 2006 | A1 |
20060192001 | Shaffer et al. | Aug 2006 | A1 |
20060201961 | Abdulhay et al. | Sep 2006 | A1 |
20060238338 | Nanda | Oct 2006 | A1 |
20060256664 | Varon | Nov 2006 | A1 |